-
D. Boral Capital Reiterates Buy Rating for Trevi Therapeutics (NASDAQ:TRVI)
来源: Buzz FX / 08 1月 2025 07:56:15 America/Chicago
D. Boral Capital Reiterates Buy Rating for Trevi Therapeutics (NASDAQ:TRVI) Written by MarketBeat January 8, 2025 Share Link copied to clipboard. Trevi Therapeutics ( NASDAQ:TRVI - Get Free Report ) 's stock had its "buy" rating reaffirmed
Read more...